Estimated Control (67%) Closed Transaction verified Beauty & personal careCPGK beautySkin Care

Dr. Jart+ acquired by The Estée Lauder Companies

The Estée Lauder Companies acquired Dr. Jart+, a South Korea beauty & personal care brand.

Transaction summary

Target
Dr. Jart+
Seller
-
Announced
2019-11-18
Geography
South Korea
Type
Acquisition
Deal type
Control
Stake acquired
67%
First added
2026-06-18
Latest update
2026-10-18

Value and multiples

100% enterprise value

USD 1.7B

100% enterprise value | USD

Basis: Public source

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

EV / revenue

3.4x

Period: FY2019 Forecast

Basis: Derived from source data

EV / EBITDA

-

EBITDA basis not stated

Basis: Estimated

Amounts paid and other reported values

Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.

Transaction value: USD 1.9B

Pasted spreadsheet row states USD 1,902m valuation; supplied public web evidence verifies the acquisition but does not confirm deal value.

Basis

  • Estée Lauder announced US$1.7bn whole-company EV for Have & Be and forecast Dr. Jart+ sales above US$500m for 2019. Using US$500m gives estimated forward EV/sales of 3.4x; the sales estimate covers the main acquired brand.

Other reviewed estimates

Earlier estimates and their sources.

other reviewed estimate
Revenue USD 500m
Open evidence

Source summary

100% EV basis review

Confirmed

Estée Lauder’s November 18, 2019 announcement values the total Have & Be enterprise at approximately US$1.7bn and acquires the remaining two-thirds. This is already a 100% EV; 33% was the previously held stake.

Open source

Continue your research

Explore more comps →